Goitre and student examinations

P. Henschke
DOI: https://doi.org/10.5694/j.1326-5377.1988.tb99484.x
1988-05-01
Abstract:The authorsrecount accurately our study in 1980, 2 in which we disagreed with previous reports thatStrept. pyogenes invariablycausesnon-bullous impetigo, withStaph. aureus being a secondary invader. WedemonstratedStaph. aureus in 63 of 74 cases ofpustularimpetiginous lesions. Also, Rogers et al. accurately cite our findings that Staph. aureus was thepredominantpathogen in our patients withchildhood pyoderma and, indeed, of 101 cases, Staph. aureus was grown in86010 (in 77010 by itselfand in9010 in association withStrept, pyogenes). Thus, Staph. aureus was the primary pathogen in the majority of patients with nonbullous as well as bullous impetigo. In addition to confirming that Staph. aureus had also emerged as a predominantpathogen in this large series of children in Sydney, Rogers et al. found 98010 resistance to penicillin, which was our experience, and greater than 50010 resistance of Staph. aureus to erythromycin.'This impressive degreeofStaph. aureus resistance to erythromycin concurs withour"spotchecking" ofStaph. aureus in impetigo in our community. In a study of 25 paediatric patients with impetigo in the summers of 1986and 1987, Staph. aureus was grown from 20 children. Erythromycin resistance was now present in25010 of Staph. aureus from these skin infections. In spite of the smaller number of patients who were studied, thisdemonstratedan increased prevalence of resistance inStaph. aureus to erythromycin in a patient populationthat showed a 10010prevalenceof erythromycin resistancein the original study of 1980. 2 Recent reviewsof the literature from Japan] and from Michigan in the United States' revealed a prevalence of erythromycin resistance in Staph. aureus in skin infections of over42010 and 22010, respectively. We must concur with Rogers et al.' that the usefulness of penicillin anderythromycinin the treatmentof childhood impetigo, in both our communities, is of significantly diminished value. The cloxacillin class of oral antibioticagents and the cephalosporins seem the tr atmentsof choice in thesepopulations.The need to determine the aetiology of impetigo and the sensitivities of frequently-used antibiotic agents clearly is reiterated by these findings. LawrenceSchachner, MD Director. Division of PediatricDermatology AnaGonzalez,MD Resident,Departmentof Dermatology& CutaneousSurgery University of Miami School of Medicine 1600 NW 10th Avenue. Miami, Florida 33101, USA I. Rogers M,Dorman DC, Gapes M, LyJ. A three-yearstudy of impetigo in Sydney.Med J Aus/ 1987; 147: 63-65. 2. Schachner L, Taplin D, Scott GB. Morrison M. A therapeutic updateof superficial skin infections.Pediatr Clin North Am 1983; 30: 397-405. 3. Dekio S, Takagaki K, Yamasaki R, et aI. Staphylococci isolated from pyodennasand their sensitivities to antibiotics. J Dermalol (Tokyo) 1981; 8: 215-221. 4. Coskey RJ, Caskey LA. Diagnosis and treatmentof impetigo. JAm Acad Dermatol 1987; 17: 62-63.
What problem does this paper attempt to address?